Barclays Bank Global Medium-Term Notes, Series A (Cusip: 06740LEM3)

Barclays Bank Final Prospectus Cusip: 06740LEM3Did You Invest in Barclays Bank Global Medium-Term Notes, Series A (Cusip: 06740LEM3), Linked to the Prospectus Supplement to the Prospectus dated February 10, 2009?

According to BarclaysGlobal Medium-Term Notes, Series A (Cusip: 06740LEM3):

The principal, interest or any other amounts payable on the notes, and the amount of money or warrant property payable or deliverable in respect of the warrants, may be based on, as applicable, one or more of the following or on movements in the level, value or price or other events relating to one or more of the following: indices of equity securities, equity securities, shares or other interests in exchange-traded funds, indices of commodities, commodities, indices of foreign currencies, foreign currencies, indices of interest rates, interest rates, indices of consumer prices or other asset classes.

In addition, the principal, interest or any other amounts payable on the notes, and the amount of money or warrant property payable or deliverable in respect of the warrants, may be based on measures, formulas or instruments, including those related to macroeconomic events or indicators or the occurrence or non-occurrence of any event or circumstance, or baskets comprised of any instruments or measures, as specified in the applicable pricing supplement.

Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):

FINRA-Structured-Products


If you bought the structured product known as Barclays Bank Global Medium-Term Notes, Series A (Cusip: 06740LEM3), Linked to the Prospectus Supplement to the Prospectus dated February 10, 2009, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.

Image credit: Tony Monblat via Flickr

CONTACT US FOR A FREE CONSULTATION

Se Habla Español

Contact our office today to discuss your case. You can reach us by phone at 844-689-5754 or via e-mail. To send us an e-mail, simply complete and submit the online form below.